ChiCTR-TRC-14004180: Stratified-block Randomized, Double-blind, Positive and Placebo-controlled, Multicenter and Re-evaluation of post-marketing Traditional Chinese Medicine Clinical Trial for VPB Treated with MSN Capsule |
|
|
| Completed | 4 | 900 | | XSN Capsule: oral, 4 capsules each time, three times a day；Mexiletine hydrochloride simulation agent: oral, 2 tablets (50 mg/tablet) each time, 3 times a day; ;mexiletine hydrochloride: oral, 2 tablets (50 mg/tablet) each time, 3 times a day;XSN Capsule simulation agent: oral, 4 tablets each time, 3 times a day; ;XSN Capsule simulation agent: oral, 4 tablets each time, 3 times a day;Mexiletine hydrochloride simulation agent, oral, 2 tablets (50 mg/tablet), 3 times a day | BeijingChao-YangHospital; Level of the institution：, Shanxi Momentum Pharmaceutcal Company | ventricular premature beat | | | | |
AVATAR, NCT02114528: Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention |
|
|
| Terminated | 4 | 40 | Canada | Antiarrhythmic Drug Therapy, Betapace (sotalol), Mexitil (mexiletine), Pronestyl (procainamide), Cordarone (amiodarone), Catheter ablation | Ottawa Heart Institute Research Corporation | Ventricular Tachycardia, Ventricular Arrhythmia | 11/15 | 11/15 | | |
NCT01811355: Mexiletine for the Treatment of Muscle Cramps in ALS |
|
|
| Completed | 4 | 23 | US | Mexiletine, Mexetil, Placebo, Sugar pill | Bjorn Oskarsson, MD, University of California, Davis, ALS Association | Muscle Cramps in Amyotrophic Lateral Sclerosis | 03/16 | 05/16 | | |
| Completed | 4 | 402 | US, Canada | Nortriptyline, Duloxetine, Pregabalin, Mexiletine | University of Kansas Medical Center, Patient-Centered Outcomes Research Institute | Cryptogenic Sensory Polyneuropathy | 09/17 | 09/17 | | |
